Bill > S2977

Introduced Session

Budgeting for Opioid Addiction Treatment Act This bill amends the Internal Revenue Code to impose a one cent per milligram excise tax on the sale of active opioids by the manufacturer, producer, or importer. The tax excludes prescription drugs used exclusively for the treatment of opioid addiction as part of a medically assisted treatment effort. The Department of Health and Human Services (HHS) must establish a program to provide rebates or discounts to cancer and hospice patients to ensure that they do not pay the tax. The bill amends the Public Health Service Act to require any increase in federal revenues from the tax after rebates and discounts are subtracted to be distributed to states under the Substance Abuse Prevention and Treatment Block Grant program to be used exclusively for substance abuse (including opioid abuse) efforts in the states, including specified treatment programs. HHS must report to Congress on the impact of this bill on the retail cost of opioids and patient access to opioid medication, the effectiveness of the discount or rebate for cancer and hospice patients, how the funds are being used to improve substance abuse treatment efforts, and suggestions for improving access to opioids for cancer and hospice patients and substance abuse treatment efforts.

AI Summary

Committee Categories

Joe Manchin (I)*,  Tammy Baldwin (D),  Barbara Boxer (D),  Martin Heinrich (D),  Heidi Heitkamp (D),  Angus King (I),  Amy Klobuchar (D),  Chris Murphy (D),  Bill Nelson (D),  Brian Schatz (D),  Jeanne Shaheen (D),  Elizabeth Warren (D), 

Read twice and referred to the Committee on Finance. (on 05/24/2016)

Official Document